{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T23:48:30Z","timestamp":1791935310293,"version":"4.3.4"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T00:00:00Z","timestamp":1615420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Lung cancer screening using low-dose computed tomography (LDCT) often leads to unnecessary biopsy because of the low specificity among patients with pulmonary nodules \u226410 mm. Circulating genetically abnormal cells (CACs) can be used to discriminate lung cancer from benign lung disease. To examine the diagnostic value of CACs in detecting lung cancer for patients with malignant pulmonary nodules \u226410 mm.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In this prospective study, patients with pulmonary nodules \u226410 mm who were detected at four hospitals in China from January 2019 to January 2020 were included. CACs were detected using fluorescence <jats:italic>in-situ<\/jats:italic> hybridization. All patients were confirmed as lung cancer or benign disease by further histopathological examination. Multivariable logistic regression models were established to detect the presence of lung cancer using CACs and other associated characteristics. Receiver operating characteristic analysis was used to evaluate the performance of CACs for lung cancer diagnosis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Overall, 125 patients were included and analyzed. When the cutoff value of CACs was &amp;gt;2, the sensitivity and specificity for lung cancer were 70.5 and 86.4%. Male (OR = 0.330, P = 0.005), maximum solid nodule (OR = 2.362, P = 0.089), maximum nodule located in upper lobe (OR = 3.867, P = 0.001), and CACs &amp;gt;2 (OR = 18.525, P &amp;lt; 0.001) met the P &amp;lt; 0.10 criterion for inclusion in the multivariable models. The multivariable logistic regression model that included the dichotomized CACs (&amp;gt;2 <jats:italic>vs.<\/jats:italic> \u22642) and other clinical factors (AUC = 0.907, 95% CI = 0.842\u20130.951) was superior to the models that only considered dichotomized CACs or other clinical factors and similar to the model with numerical CACs and other clinical factors (AUC = 0.913, 95% CI = 0.850\u20130.956).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>CACs presented a significant diagnostic value in detecting lung cancer for patients with pulmonary nodules \u226410 mm.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2021.638223","type":"journal-article","created":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T07:28:38Z","timestamp":1615447718000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Circulating Genetically Abnormal Cells Add Non-Invasive Diagnosis Value to Discriminate Lung Cancer in Patients With Pulmonary Nodules \u226410 mm"],"prefix":"10.3389","volume":"11","author":[{"given":"Maosong","family":"Ye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxuan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juncheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuoji","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zilong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianjun","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanci","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Botao","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayuan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxue","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,3,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2019.0059","article-title":"NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 1.2020","volume":"17","year":"2019","journal-title":"J Natl Compr Canc Netw"},{"key":"B2","unstructured":"NCCN Clinical Practice Guidelines in Oncology. Lung Cancer Screening2020"},{"key":"B3","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1056\/NEJMoa1102873","article-title":"Reduced lung-cancer mortality with low-dose computed tomographic screening","volume":"365","author":"Aberle","year":"2011","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa060476","article-title":"Survival of patients with stage I lung cancer detected on CT screening","volume":"355","author":"Henschke","year":"2006","journal-title":"N Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201404-0603OC","article-title":"Assessment of a Combined Panel of Six Serum Tumor Markers for Lung Cancer","volume":"193","author":"Molina","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1177\/1177271917751608","article-title":"Evaluation of a Serum Lung Cancer Biomarker Panel","volume":"13","author":"Mazzone","year":"2018","journal-title":"Biomark Insights"},{"key":"B7","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12967-015-0419-y","article-title":"Performance of a multiplexed dual analyte immunoassay for the early detection of non-small cell lung cancer","volume":"13","author":"Doseeva","year":"2015","journal-title":"J Transl Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-09-3358","article-title":"Genetically abnormal circulating cells in lung cancer patients: an antigen-independent fluorescence in situ hybridization-based case-control study","volume":"16","author":"Katz","year":"2010","journal-title":"Clin Cancer Res"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/s1525-1578(10)60459-x","article-title":"Chromosomal abnormalities in non-small cell lung carcinomas and in bronchial epithelia of high-risk smokers detected by multi-target interphase fluorescence in situ hybridization","volume":"5","author":"Romeo","year":"2003","journal-title":"J Mol Diagn"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)62521-7","article-title":"Persistent increase in chromosome instability in lung cancer: possible indirect involvement of p53 inactivation","volume":"159","author":"Haruki","year":"2001","journal-title":"Am J Pathol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1378\/chest.111.6.1691","article-title":"Detection of chromosomal aneuploidy by interphase fluorescence in situ hybridization in bronchoscopically gained cells from lung cancer patients","volume":"111","author":"Schenk","year":"1997","journal-title":"Chest"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/0165-4608(95)00355-x","article-title":"Detection of aneuploidy in interphase nuclei from non-small cell lung carcinomas by fluorescence in situ hybridization using chromosome-specific repetitive DNA probes","volume":"89","author":"Taguchi","year":"1996","journal-title":"Cancer Genet Cytogenet"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/s0169-5002(00)00097-0","article-title":"Aneuploidy of chromosome 7 can be detected in invasive lung cancer and associated premalignant lesions of the lung by fluorescence in situ hybridisation","volume":"28","author":"Zojer","year":"2000","journal-title":"Lung Cancer"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/cncy.22278","article-title":"Identification of circulating tumor cells using 4-color fluorescence in situ hybridization: Validation of a noninvasive aid for ruling out lung cancer in patients with low-dose computed tomography-detected lung nodules","volume":"128","author":"Katz","year":"2020","journal-title":"Cancer Cytopathol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2016.03.025","article-title":"The IASLC Lung Cancer Staging Project: Proposals for Coding T Categories for Subsolid Nodules and Assessment of Tumor Size in Part-Solid Tumors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer","volume":"11","author":"Travis","year":"2016","journal-title":"J Thorac Oncol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200602-160OC","article-title":"Diagnostic percutaneous transthoracic needle biopsy does not affect survival in stage I lung cancer","volume":"174","author":"Wisnivesky","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1378\/chest.11-1821","article-title":"Diagnostic performance of percutaneous core-needle lung biopsy under CT scan fluoroscopic guidance for pulmonary lesions measuring \u226410 mm","volume":"140","author":"Yamauchi","year":"2011","journal-title":"Chest"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1378\/chest.126.3.744","article-title":"Percutaneous needle biopsy for small lung nodules beneath the rib under CT scan fluoroscopic guidance with gantry tilt","volume":"126","author":"Yamagami","year":"2004","journal-title":"Chest"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1148\/rg.2018180017","article-title":"Updated Fleischner Society Guidelines for Managing Incidental Pulmonary Nodules: Common Questions and Challenging Scenarios","volume":"38","author":"Bueno","year":"2018","journal-title":"Radiographics"},{"key":"B21","first-page":"5","article-title":"Early detection of lung cancer: clinical perspectives of recent advances in biology and radiology","volume":"7","author":"Hirsch","year":"2001","journal-title":"Clin Cancer Res"},{"key":"B22","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1146\/annurev.physiol.64.081501.155828","article-title":"Molecular pathogenesis of lung cancer","volume":"64","author":"Zochbauer-Muller","year":"2002","journal-title":"Annu Rev Physiol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djn419","article-title":"Anti-epithelial cell adhesion molecule antibodies and the detection of circulating normal-like breast tumor cells","volume":"101","author":"Sieuwerts","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1053\/j.semtcvs.2015.04.001","article-title":"Using Clinical Risk Models for Lung Nodule Classification","volume":"27","author":"Deppen","year":"2015","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1378\/chest.06-1261","article-title":"A clinical model to estimate the pretest probability of lung cancer in patients with solitary pulmonary nodules","volume":"131","author":"Gould","year":"2007","journal-title":"Chest"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2016.02.650","article-title":"Evaluation of Pulmonary Nodules: Clinical Practice Consensus Guidelines for Asia","volume":"150","author":"Bai","year":"2016","journal-title":"Chest"},{"key":"B27","doi-asserted-by":"publisher","first-page":"26","DOI":"10.2967\/jnumed.119.229575","article-title":"Pulmonary Lymphangitic Carcinomatosis: Diagnostic Performance of High-Resolution CT and (18)F-FDG PET\/CT in Correlation with Clinical Pathologic Outcome","volume":"61","author":"Jreige","year":"2020","journal-title":"J Nucl Med"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.638223\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T07:28:45Z","timestamp":1615447725000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.638223\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,11]]},"references-count":27,"alternative-id":["10.3389\/fonc.2021.638223"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2021.638223","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,11]]},"article-number":"638223"}}